Hedge Fund - Rock Springs Capital Management
Neurocrine Biosciences Inc (NBIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $157,584,960 | 3.87% | 1,196,000 | $115.11 |
| 2 | 2023 - Q3 (2023-09-30) | $139,050,000 | 3.72% | 1,236,000 | $105.30 |
| 3 | 2023 - Q2 (2023-06-30) | $120,656,850 | 2.87% | 1,279,500 | $97.71 |
| 4 | 2023 - Q1 (2023-03-31) | $122,486,322 | 2.92% | 1,210,100 | $104.06 |
| 5 | 2022 - Q4 (2022-12-31) | $134,071,400 | 3.22% | 1,122,500 | $117.13 |
| 6 | 2022 - Q3 (2022-09-30) | $119,221,000 | 3.07% | 1,122,500 | $101.46 |
| 7 | 2022 - Q2 (2022-06-30) | $109,421,000 | 3.18% | 1,122,500 | $92.29 |
| 8 | 2022 - Q1 (2022-03-31) | $103,594,000 | 2.6% | 1,105,000 | $84.75 |
| 9 | 2021 - Q4 (2021-12-31) | $94,113,000 | 2.17% | 1,105,000 | $91.99 |
| 10 | 2021 - Q3 (2021-09-30) | $100,849,000 | 2.12% | 1,051,500 | $94.46 |
| 11 | 2021 - Q2 (2021-06-30) | $98,780,000 | 1.95% | 1,015,000 | $95.85 |
| 12 | 2021 - Q1 (2021-03-31) | $98,709,000 | 2.15% | 1,015,000 | $104.86 |
| 13 | 2020 - Q4 (2020-12-31) | $150,964,000 | 3.2% | 1,575,000 | $96.59 |
| 14 | 2020 - Q3 (2020-09-30) | $140,922,000 | 3.57% | 1,465,500 | $115.68 |
| 15 | 2020 - Q2 (2020-06-30) | $166,713,000 | 4.57% | 1,366,500 | $110.51 |
| 16 | 2020 - Q1 (2020-03-31) | $116,799,000 | 4.82% | 1,349,500 | $97.87 |
| 17 | 2019 - Q4 (2019-12-31) | $137,372,000 | 4.34% | 1,278,000 | $104.70 |
| 18 | 2019 - Q3 (2019-09-30) | $111,061,000 | 4.42% | 1,232,500 | $93.43 |
| 19 | 2019 - Q2 (2019-06-30) | $86,372,000 | 3.12% | 1,023,000 | $82.11 |
| 20 | 2019 - Q1 (2019-03-31) | $74,400,000 | 2.86% | 844,500 | $83.58 |
| 21 | 2018 - Q4 (2018-12-31) | $56,314,000 | 2.65% | 788,600 | $95.81 |
| 22 | 2018 - Q3 (2018-09-30) | $79,303,000 | 2.87% | 645,000 | $113.46 |
| 23 | 2018 - Q2 (2018-06-30) | $61,930,000 | 2.38% | 630,400 | $89.51 |
| 24 | 2018 - Q1 (2018-03-31) | $50,272,000 | 2.14% | 606,200 | $84.45 |
| 25 | 2017 - Q4 (2017-12-31) | $37,709,000 | 1.71% | 486,000 | $68.21 |
| 26 | 2017 - Q3 (2017-09-30) | $26,963,000 | 1.24% | 440,000 | $52.77 |
| 27 | 2017 - Q2 (2017-06-30) | $19,274,000 | 0.97% | 419,000 | $48.51 |
| 28 | 2017 - Q1 (2017-03-31) | $17,753,000 | 1.02% | 410,000 | $42.84 |
| 29 | 2016 - Q4 (2016-12-31) | $15,867,000 | 1.06% | 410,000 | $45.27 |
| 30 | 2016 - Q3 (2016-09-30) | $20,762,000 | 1.3% | 410,000 | $49.80 |
| 31 | 2016 - Q2 (2016-06-30) | $18,612,000 | 1.37% | 409,500 | $46.04 |
| 32 | 2016 - Q1 (2016-03-31) | $15,998,000 | 1.34% | 404,500 | $39.68 |
| 33 | 2015 - Q4 (2015-12-31) | $21,355,000 | 1.61% | 377,500 | $50.83 |
| 34 | 2015 - Q3 (2015-09-30) | $14,881,000 | 1.2% | 374,000 | $48.33 |
| 35 | 2015 - Q2 (2015-06-30) | $17,958,000 | 1.31% | 376,000 | $42.40 |
| 36 | 2015 - Q1 (2015-03-31) | $14,891,000 | 1.39% | 375,000 | $35.77 |
| 37 | 2014 - Q4 (2014-12-31) | $8,042,000 | 0.94% | 360,000 | $18.95 |
| 38 | 2014 - Q3 (2014-09-30) | $4,936,000 | 0.76% | 315,000 | $14.95 |
| 39 | 2014 - Q2 (2014-06-30) | $4,600,000 | 0.82% | 310,000 | $14.11 |
| 40 | 2014 - Q1 (2014-03-31) | $4,830,000 | 1.11% | 300,000 | $17.10 |
The displayed share prices are average quarterly stock market prices.